Parents and doctors of children with heart disease have a new resource as they seek the best diagnostics with the least radiation. Called the “Have-a-Heart” campaign, it’s a collaborative effort led by the Image Gently Alliance together with the American Academy of Pediatrics and a coalition of pediatric medicine and cardiology organizations.

Physicians in fields like cardiology have traditionally looked to clinical practice guidelines to help articulate the best evidence-based care for patients. The rapidly growing movement to value-based care is prompting clinicians—including echocardiographers—to carefully weigh a more focused and integrative approach to delivering consistent, quality medicine: care pathways.

Patients at Terrebonne General Medical Center (TGMC) now have access to safe, high-quality interventional cardiac exams with the installation of Toshiba Medical’s InfinixTM-i Sky +. TGMC, a nationally recognized healthcare organization and home to one of the most advanced vascular interventional practices in the country, is the first healthcare provider in the United States to install the Infinix-i Sky +.

A recent article by Science Bulletin shows an image of a prostate cancer patient with metastatic tumors and another image of the same patient three months later with those tumors gone. 

Neuroscientist Greg Dunn, PhD, and applied physicist Brian Edwards, PhD, have teamed up to create an artistic series of brain images using a technique called reflective microetching. The two describe the work as “the most fundamental self-portrait ever created."

Compared side-by-side with standard cardiac CT for calcium scoring, ultralow-dose CT shows good sensitivity, specificity and overall accuracy despite its markedly lower radiation dose. In fact, it’s unlikely to miss coronary calcification in patients with at least moderate calcium load and could offer a sensible alternative for some patients sent for coronary CT angiography.

The National Institutes of Health has awarded Naren Vyavahare $1.47 million to advance research into abdominal aortic aneurysms (AAA).

The U.S. Food and Drug Administration (FDA) approved the marketing of the Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue.